International journal of cancer

JAMA

blood advances

Haematologica

histopathology

american journal of perinatology

journal of molecular and cellular cardiology

[1] Metabolic reprogramming orchestrates CD4 T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice.

[2] Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

[3] Challenges and limitations of primary diagnosis of T-cell and NK/T-cell lymphoma in bone marrow biopsy.

[4] Metabolic Factors Contribute to T-cell Inhibition in the Ovarian Cancer Ascites.

[5] Multicenter Experience with Neurally Adjusted Ventilatory Assist in Infants with Severe Bronchopulmonary Dysplasia.

[6] RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

[7] Interferon-complement loop in transplant-associated thrombotic microangiopathy.

[8] Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

[9] Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

[10] Resonant Photoacoustic Spectroscopy of NO2 with a UV-LED Based Sensor

[11] Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT).

[12] Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

[13] The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells

[14] Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

[15] Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

[16] Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice.

[17] The soluble isoform of CTLA-4 as a regulator of T-cell responses.

[18] Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?

[19] Methamphetamine functions as a novel CD4⁺ T-cell activator via the sigma-1 receptor to enhance HIV-1 infection

[20] The pipeline of antiviral T-cell therapy: what's in the clinic and undergoing development.

[21] Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

[22] Inhibition of Cytokine Production and Cytokine-Stimulated T-Cell Activation by FK506 (Tacrolimus)1

[23] Dual T-cell Depletion with ATG and PTCy Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-HSCT.

[24] Metabolic reprogramming orchestrates CD4 T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice.

[25] Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies.

[26] Erratum: Correction to Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem (ACS nano (2012) 6 12 (10646-10657))

[27] Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.

[28] A structure-based rationale for sialic acid independent host-cell entry of Sosuga virus.

[29] Differences for T-Cell Subtypes in Aspiration Biopsies of Patients With Kidney Transplant Under Polyclonal and Monoclonal Immunosuppressive Treatments.

[30] Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

[31] Correction to: T-cell aging in end-stage renal disease: an evolving story with CMV (Medical Microbiology and Immunology, (2019), 208, 3-4, (281-287), 10.1007/s00430-019-00596-8)

[32] Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.

[33] Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.

[34] CD39 identifies a microenvironment-specific anti-inflammatory CD8 ⁺ T-cell population in atherosclerotic lesions

[35] Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients

[36] Coarse-to-Fine Adversarial Networks and Zone-based Uncertainty Analysis for NK/T-cell Lymphoma Segmentation in CT/PET images.

[37] Challenges and limitations of primary diagnosis of T-cell and NK/T-cell lymphoma in bone marrow biopsy.

[38] Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia

[39] Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition.

[40] Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing

[41] Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

[42] Metabolic Factors Contribute to T-cell Inhibition in the Ovarian Cancer Ascites.

[43] Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154Aspergillus fumigatus specific T-cell quantification.

[44] Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.

[45] Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

[46] Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.

[47] Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo

[48] Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

[49] Cytotoxic T-cell response to respiratory syncytial virus in mice.

[50] Testosterone Inhibits Adipogenic Differentiation in 3T3-L1 Cells: Nuclear Translocation of Androgen Receptor Complex with β-Catenin and T-Cell Factor 4 May Bypass Canonical Wnt Signaling to Down-Regulate Adipogenic Transcription Factors

[51] The Effects of CCR9+ and CD103+ Dendritic Cells on Regulatory T-cells in Food Allergy

[52] CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration

[53] Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

[54] Establishment of an etiologic relationship between the human T-cell leukemia/lymphoma virus (HTLV) and adult T-cell leukemia

[55] Cytotoxic T-cell response to respiratory syncytial virus in mice

[56] pathophysiology of cd4+ t-cell depletion in hiv-1 and hiv-2 infections

[57] frequency patterns of t-cell exposed motifs in immunoglobulin heavy chain peptides presented by mhcs

[58] advancing car t-cell therapy for solid tumors: lessons learned from lymphoma treatment

[59] fatal peripheral t-cell lymphoma presenting as hypereosinophilia and spontaneous tumor lysis syndrome: a rare case report

[60] inducible t-cell co-stimulator impacts chronic graft-versus-host disease by regulating both pathogenic and regulatory t cells

[61] on the effect of unit-cell parameters in predicting the elastic response of wood-plastic composites

[62] corrigendum: monitoring t-cell responses in translational studies: optimization of dye-based proliferation assay for evaluation of antigen-specific responses

[63] t-cell/histiocyte rich b-cell lymphoma of mass in caecum and part of ascending colon

[64] rapid cloning, expression, and functional characterization of paired αβ and γδ t-cell receptor chains from single-cell analysis

[65] aplicación de la citometría de flujo en el diagnóstico inmunológico de los linfomas cutáneos t application of flow cytometry in the immunological diagnosis of cutaneous t-cell lymphomas

[66] death caused by possible unrecognized (too late recognized) mycobacterium gordonae infection in a patient with angioimmunoblastic t-cell lymphoma

[67] selection of tumor-specific cytotoxic t lymphocytes in acute myeloid leukemia patients through the identification of t-cells capable to establish stable interactions with the leukemic cells: “doublet technology”

[68] the pretreatment albumin to globulin ratio predicts survival in patients with natural killer/t-cell lymphoma

[69] prediction of immunological t-cell epitopes of hepatitis c virus genotype 5a

[70] the use of humoral responses as a marker of cmv burden in hiv patients on art requires consideration of t-cell recovery and persistent b-cell activation

[71] evaluation of epstein-barr virus latent membrane protein 2 specific t-cell receptors driven by t-cell specific promoters using lentiviral vector

[72] recruitment of bad by the chlamydia trachomatis vacuole correlates with host-cell survival.

[73] leukemic phase of hepatosplenic t-cell lymphoma: a great masquerader of acute leukemia

[74] beyond the antigen receptor: editing the genome of t-cells for cancer adoptive cellular therapies

[75] morbidity and causes of death in patients with cutaneous t-cell lymphoma in finland

[76] when aging reaches cd4+ t-cells: phenotypic and functional changes

[77] study of t-cell subsets, b and nk cells in iranian patients with behcet's disease by monoclonal antibodies

[78] chidamide in the treatment of peripheral t-cell lymphoma

[79] stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta t-cell lymphoma

[80] angioimmunoblastic t-cell lymphoma: a mimic for lupus

[81] human t-cell lymphotropic virus (htlv) infection in uruguay: identification of problems prevalence estimation, screening analysis and clinical management in blood donors in the 2012-2014 period

[82] pseudomembranous tracheitis caused by aspergillus fumigatus in the setting of high grade t-cell lymphoma

[83] the cyp2b6 g516t polymorphism influences cd4+ t-cell counts in hiv-positive patients receiving antiretroviral therapy in an ethnically diverse region of the amazon

[84] cd28 blockade ex vivo induces alloantigen-specific immune tolerance but preserves t-cell pathogen reactivity

[85] salt tolerance at single cell level in giant-celled characeae

[86] lowering the limit: reducing the cd4 t-cell threshold for ophthalmic screening in patients with hiv in an ethnically diverse uk population

[87] elevated mir-155 expression induces immunosuppression via cd39+ regulatory t-cells in sepsis patient

[88] granulocytic myeloid-derived suppressor cells (gr-mdsc) in breast milk (bm); gr-mdsc accumulate in human bm and modulate t-cell and monocyte function

[89] human t-cell lymphotropic virus type i (htlv-i) proviral dna viral load among asymptomatic patients and patients with htlv-i-associated myelopathy/tropical spastic paraparesis

[90] case report: esophageal and gastric t-cell lymphoma: a rare entity

[91] evaluation of a dry format reagent for cd4+ and cd8+ t-cell enumeration with facscount and guava polymerase chain reaction

[92] dynamic perturbations of the t-cell receptor repertoire in chronic hiv infection and following antiretroviral therapy.

[93] adult t-cell leukemia/lymphoma with cll-like morphology—a case report

[94] peripheral t-cell lymphoma: frequency and distribution in a tertiary referral center in south india

[95] extranodal natural killer/t-cell lymphoma, nasal type: a rare but critical diagnosis

[96] mycobacterium tuberculosis modulates mir-106b-5p to control cathepsin s expression resulting in higher pathogen survival and poor t-cell activation

[97] contribution of mesenteric lymph nodes and galt to the intestinal foxp3+ regulatory t-cell compartmentsummary

[98] new insight into the pathogenesis of erythema nodosum leprosum: the role of activated memory t-cells

[99] microrna181a is overexpressed in t-cell leukemia/lymphoma and related to chemoresistance

[100] regulatory t-cell profile in early and late lesions of cutaneous leishmaniasis due to leishmania major

[101] the immunomodulator vaca promotes immune tolerance and persistent helicobacter pylori infection through its activities on t-cells and antigen-presenting cells